YETI Holdings
YETI
Halozyme Therapeutics
HALO
eBay
EBAY
4
Constellation Brands
STZ
5
Workday
WDAY
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Total investments | 21.19%83.66B | 21.59%80.25B | 21.59%80.25B | 28.33%79.4B | 22.09%72.36B | 21.79%69.04B | 23.25%66B | 23.25%66B | 18.23%61.87B | 14.13%59.27B |
-Equity investments | 19.72%72.58B | 12.32%4.3B | 12.32%4.3B | 1,932.22%70.79B | 1,635.42%64.09B | 1,465.32%60.63B | -5.05%3.83B | -5.05%3.83B | -11.13%3.48B | -10.90%3.69B |
-Short term investments | 31.74%11.08B | 22.16%75.95B | 22.16%75.95B | -85.25%8.61B | -85.13%8.26B | -84.07%8.41B | 25.56%62.17B | 25.56%62.17B | 20.61%58.39B | 16.30%55.57B |
Cash and cash equivalents | 26.21%195M | 68.24%143M | 68.24%143M | 10.20%136.1M | -44.97%90.2M | -43.55%154.5M | -58.23%85M | -58.23%85M | -64.80%123.5M | -27.51%163.9M |
Restricted cash and cash equivalents | -10.45%12M | -26.67%11M | -26.67%11M | -26.85%10.9M | -26.28%11.5M | -10.07%13.4M | -13.79%15M | -13.79%15M | 3.47%14.9M | 8.33%15.6M |
Receivables | 10.75%21.26B | 12.21%19.13B | 12.21%19.13B | 12.84%20.02B | 9.19%19.43B | 6.48%19.2B | 4.94%17.05B | 4.94%17.05B | 3.29%17.74B | 14.61%17.79B |
-Accounts receivable | 10.75%21.26B | 12.21%19.13B | 12.21%19.13B | 12.84%20.02B | 9.19%19.43B | 6.48%19.2B | 4.94%17.05B | 4.94%17.05B | 3.29%17.74B | 14.61%17.79B |
Accrued investment income | 25.81%584M | 35.62%594M | 35.62%594M | 48.19%560.3M | 59.26%564.1M | 54.99%464.2M | 55.04%438M | 55.04%438M | 73.92%378.1M | 63.45%354.2M |
Prepaid assets | 45.85%306M | 39.60%349M | 39.60%349M | -4.68%224M | 19.72%290.8M | -22.18%209.8M | -15.40%250M | -15.40%250M | -36.05%235M | -47.68%242.9M |
Deferred policy acquisition costs | 13.74%2.07B | 16.24%1.96B | 16.24%1.96B | 17.29%2.03B | 14.99%1.94B | 11.77%1.82B | 9.23%1.69B | 9.23%1.69B | 9.27%1.73B | 12.49%1.69B |
Net PPE | 12.92%854M | -10.33%790M | -10.33%790M | -25.11%688.8M | -27.86%713.5M | -20.31%756.3M | -14.80%881M | -14.80%881M | -13.80%919.8M | -12.07%989M |
Goodwill and other intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -5.29%302.8M | -5.97%305.7M |
-Goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%227.9M | 0.00%227.9M |
-Other intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -18.41%74.9M | -19.96%77.8M |
Other assets | 11.08%1.61B | 15.65%1.56B | 15.65%1.56B | 56.82%1.54B | 60.84%1.5B | 61.76%1.45B | 16.32%1.35B | 16.32%1.35B | 18.37%979.6M | 19.84%934M |
Total assets | 18.36%111.41B | 19.23%105.75B | 19.23%105.75B | 22.82%105.2B | 18.02%97.89B | 17.06%94.13B | 17.53%88.69B | 17.53%88.69B | 13.41%85.65B | 13.53%82.95B |
Liabilities | ||||||||||
Policy holders liabilities reserve | 15.06%66.43B | 15.39%62.92B | 15.39%62.92B | 15.63%62.83B | 14.13%60.29B | 13.50%57.74B | 14.42%54.52B | 14.42%54.52B | 12.20%54.34B | 17.16%52.82B |
Long term debt and capital lease obligation | 0.06%6.89B | 0.06%6.89B | 0.06%6.89B | 0.06%6.89B | 0.06%6.89B | 7.83%6.89B | 7.84%6.89B | 7.84%6.89B | 7.83%6.89B | 7.83%6.89B |
-Long term debt | 0.06%6.89B | 0.06%6.89B | 0.06%6.89B | 0.06%6.89B | 0.06%6.89B | 7.83%6.89B | 7.84%6.89B | 7.84%6.89B | 7.83%6.89B | 7.83%6.89B |
Other liabilities | 18.71%9.13B | 47.76%10.35B | 47.76%10.35B | 18.30%8.32B | 13.06%7.38B | 22.46%7.69B | 26.55%7B | 26.55%7B | 18.52%7.03B | 9.99%6.52B |
Total liabilities | 14.02%82.46B | 17.16%80.15B | 17.16%80.15B | 14.34%78.04B | 12.56%74.55B | 13.82%72.32B | 14.84%68.41B | 14.84%68.41B | 12.36%68.26B | 15.38%66.23B |
Shareholders'equity | ||||||||||
Share capital | 0.05%586M | -45.69%586M | -45.69%586M | -45.70%585.8M | -45.73%585.7M | -45.73%585.7M | 0.02%1.08B | 0.02%1.08B | -0.01%1.08B | 0.04%1.08B |
-common stock | 0.05%586M | 0.17%586M | 0.17%586M | 0.14%585.8M | 0.07%585.7M | 0.05%585.7M | 0.02%585M | 0.02%585M | -0.02%585M | 0.07%585.3M |
-Preferred stock | ---- | --0 | --0 | --0 | --0 | --0 | 0.02%494M | 0.02%494M | 0.00%493.9M | 0.00%493.9M |
Paid-in capital | 6.47%2.16B | 6.56%2.15B | 6.56%2.15B | 5.98%2.1B | 6.45%2.06B | 6.34%2.03B | 6.34%2.01B | 6.34%2.01B | 7.52%1.98B | 6.64%1.94B |
Retained earnings | 27.17%26.73B | 29.16%24.28B | 29.16%24.28B | 41.72%24.63B | 37.06%22.41B | 30.72%21.02B | 19.59%18.8B | 19.59%18.8B | 15.97%17.38B | 9.24%16.35B |
Gains losses not affecting retained earnings | 71.27%-524M | 11.94%-1.42B | 11.94%-1.42B | 94.93%-154.4M | 35.35%-1.72B | 17.06%-1.82B | 42.33%-1.62B | 42.33%-1.62B | 2.80%-3.04B | -20.14%-2.65B |
Total stockholders'equity | 32.75%28.95B | 26.21%25.59B | 26.21%25.59B | 56.13%27.16B | 39.67%23.34B | 29.30%21.81B | 27.60%20.28B | 27.60%20.28B | 17.73%17.4B | 6.76%16.71B |
Total equity | 32.75%28.95B | 26.21%25.59B | 26.21%25.59B | 56.13%27.16B | 39.67%23.34B | 29.30%21.81B | 27.60%20.28B | 27.60%20.28B | 17.73%17.4B | 6.76%16.71B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |